PROK
ProKidney Corp.
NASDAQ · Healthcare · Biotechnology · US
$2.01
+4.69%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 429.39x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.48x
- Price / sales
- 513.38x
- Price / cash flow
- -2.97x
Enterprise value
- Enterprise value
- $1.3B
- EV / sales
- 1648.25x
- EV / EBITDA
- -8.39x
- EV / EBIT
- -7.61x
- Market cap
- $419.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026